Is Corona Remedies’ IPO a compelling bet for long-term wealth creation?

December 8, 2025

Corona Remedies is set to raise ₹655.4 crore via an offer for sale. The company focuses on specialist doctors, driving faster revenue growth than the Indian pharmaceutical market. Its sales grew by 13.6% compared to the market’s 7.9%. Revenue and net profit have shown strong annual growth. Investors with a high-risk appetite can consider this IPO for the long term.

More To Explore

Market Trading Guide: YES Bank among two stock picks for Monday with up to 10% upside scope

Equity markets saw broad-based selling pressure after weak monsoon forecasts raised concerns over food inflation, though falling crude oil prices and easing bond yields helped

May 31, 2026

Equity mutual funds deliver up to 7% return last week; international funds lead. Check top 8 performers with over 3% gains

Equity mutual funds generated strong returns last week, with international funds dominating the performance chart. Mirae Asset Global X Artificial Intelligence & Technology ETF FoF

May 31, 2026

Advertiser Disclosure

Great-investor.com helps users across the globe to find out The latest news, Guides, and Info about finance and investments. Furthermore, our content and research teams do not participate in any advertising planning nor are they permitted access to advertising campaign data.

Disclaimer

It is our organization’s primary mission to provide reviews, commentary, and analysis that are unbiased and objective. While great-investor.com has some data verified by industry participants, it can vary from time to time. Operating as an online business, this site may be compensated through third party advertisers. Our receipt of such compensation shall not be construed as an endorsement or recommendation by great-investor.com, nor shall it bias our reviews, analysis, and opinions. Please see our General Disclaimers for more information.

The information on this website does not constitute investment advice or a recommendation or a solicitation to engage in any investment activity. This website and its content are not intended for residents of the UAE, US, Canada, Australia, UK, Russia, North Korea, China, Japan, Hong Kong, Singapore and Iran.

Top10 International FZ LLE | 17th Floor, Creative Tower | 4422 | Fujairah | TRN: 100608946800003